CIM
CELG

Contravisory Investment Management’s Celgene Corp CELG Stock Holding History

Contravisory Investment Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-670
Closed -$62K – 316
2019
Q2 		$62K Buy
+670
New +$63.6K 0.02% 214
2017
Q4 		– Sell
-102
Closed -$15K – 561
2017
Q3 		$15K Buy
+102
New +$13.9K 0.01% 255
2016
Q1 		– Sell
-17
Closed -$2K – 248
2015
Q4 		$2K Buy
+17
New +$1.97K ﹤0.01% 204
2014
Q2 		– Sell
-140,672
Closed -$9.82M – 203
2014
Q1 		$9.82M Buy
+140,672
New +$11.1M 1.93% 34

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Contravisory Investment Management's CELG Position: Q3 2019 in Review

Contravisory Investment Management sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 670 shares — an estimated $62K sold.

Contravisory Investment Management first reported a position in CELG in Q1 2014 and held it in 4 quarters. The position peaked at $9.82M in Q1 2014. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Contravisory Investment Management reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Contravisory Investment Management sold 670 Celgene Corp shares in Q3 2019, an estimated $62K.
  • Contravisory Investment Management first reported a position in Celgene Corp in Q1 2014 and held it in 4 quarters.
  • Contravisory Investment Management's Celgene Corp position peaked at $9.82M in Q1 2014.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Contravisory Investment Management's 13F filing for Q3 2019, filed 7 Oct 2019.